Ask the people why they bought RNN and will hold long for three SOLID REASONS !
Archexin® (Phase IIa) a BEST IN CLASS compound that blocks both the activated and native forms of Akt1 and has FDA orphan drug designation for the treatment of pancreatic cancer, ovarian cancer, stomach cancer, RCC, and glioblastoma.
RX-3117 (Phase I) a BEST IN CLASS inhibitor of DNA synthesis under co-development with Teva Pharmaceutical that exhibits high bioavailability and may have a superior safety profile compared to gemcitabine, the current first-line therapy for pancreatic and other cancers.
RX-5902 (Phase I) a first-in-class small molecule that inhibits the phosphorylated p68 RNA helicase, a protein that plays a key role in cancer growth, progression and metastasis.
REMEMBER THOSE WORDS "BEST IN CLASS" when #$%$ sucking shorts that stole your shares like Luna talked you into doubt of BEST IN CLASS and the stock blows past 2 dollars just on Phase 1bs and Archexin is on the market and for sale streaming in revenue within two year time frame,,,,MAX! Yep when it's at 50 dollars plus go back to Lunas post, tighten that rope around your neck and get it over with....your dumb, face it.